Medtronic (MDT)
(Real Time Quote from BATS)
$81.20 USD
-0.31 (-0.38%)
Updated Aug 5, 2024 09:54 AM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Medtronic (MDT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$91.78 | $105.00 | $76.00 | 12.60% |
Price Target
Based on short-term price targets offered by 23 analysts, the average price target for Medtronic comes to $91.78. The forecasts range from a low of $76.00 to a high of $105.00. The average price target represents an increase of 12.6% from the last closing price of $81.51.
Analyst Price Targets (23)
Broker Rating
Medtronic currently has an average brokerage recommendation (ABR) of 2.44 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 27 brokerage firms. The current ABR compares to an ABR of 2.44 a month ago based on 27 recommendations.
Of the 27 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 37.04% and 3.7% of all recommendations. A month ago, Strong Buy made up 37.04%, while Buy represented 3.7%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 13 | 13 | 13 | 13 | 13 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 3 | 3 | 3 | 3 | 1 |
ABR | 2.44 | 2.44 | 2.44 | 2.44 | 2.24 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/12/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
7/10/2024 | Not Identified | Not Identified | Hold | Hold |
6/26/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/30/2024 | Goldman Sachs | David H Roman | Not Available | Strong Sell |
5/24/2024 | Truist Securities | Richard Newitter | Hold | Hold |
5/24/2024 | Needham & Company | Michael Matson | Hold | Hold |
5/24/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
5/24/2024 | Not Identified | Not Identified | Hold | Hold |
5/24/2024 | UBS | Danielle Antalffy | Strong Sell | Strong Sell |
5/20/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
4/16/2024 | Robert W. Baird & Co. | David Rescott | Hold | Hold |
4/1/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
3/15/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
3/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
2/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
2/21/2024 | Not Identified | Not Identified | Hold | Hold |
2/20/2024 | Not Identified | Not Identified | Hold | Hold |
12/21/2023 | BTIG | Ryan Zimmerman | Not Available | Hold |
11/21/2023 | William Blair | Margaret Kaczor | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.44 |
ABR (Last week) | 2.44 |
# of Recs in ABR | 27 |
Average Target Price | $91.78 |
LT Growth Rate | 6.30% |
Industry | Medical - Products |
Industry Rank by ABR | 101 of 253 |
Current Quarter EPS Est: | 1.20 |